The company claims that Dexlansoprazole delayed release capsules is the generic version of Takeda’s Dexilant which is indicated as a once-daily oral treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).
Handa Pharmaceuticals is a specialty pharmaceutical company established in the San Francisco Bay area in November 2005.